查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
牙科軟組織再生市場-全球和區域分析：按產品類型、應用、最終用戶和區域-分析和預測（2025-2035年）
市場調查報告書
商品編碼
1814818

牙科軟組織再生市場-全球和區域分析：按產品類型、應用、最終用戶和區域-分析和預測（2025-2035年）

Dental Soft-tissue Regeneration Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, Country, and Region- Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 100 Pages | 商品交期: 1-5個工作天內

價格

全球牙科軟組織再生市場 - 分析與預測（2025-2035）

牙齒軟組織再生是一種目的是修復和再生口腔內軟組織（如牙齦、牙周膜和黏膜）的醫療過程。

這種再生治療致力於促進因牙周病（牙周炎）、外傷或拔牙、植入等牙科手術後遺症而受損或流失的組織的自然癒合和再生。這個過程對於維持口腔的功能健康和美觀非常重要。軟組織再生在預防牙齦萎縮、支持植入以及恢復牙齦外觀方面發揮重要作用。

牙齒軟組織再生的治療方法包括牙齦移植、富血小板血漿（PRP）和富血小板纖維蛋白（PRF）治療、生物材料、雷射治療以及進行的幹細胞治療研究。再生牙科領域在牙周病管理和植入治療中正變得越來越重要，而健康強健的軟組織對於牙科治療的長期成功非常重要。

牙齦萎縮和牙周炎等牙周疾病的盛行率不斷上升，是牙科軟組織再生市場的主要驅動力之一。隨著這些疾病在世界各地日益普遍，對能夠再生受損牙周組織、恢復口腔健康並改善美觀的有效治療方法的需求也日益成長。牙周病影響相當一部分人口，通常會導致牙齦組織退化，如果不及時治療，甚至會導致牙齒脫落。

解決這些問題的必要性，以及人們日益意識到保持牙齦健康對整體口腔健康的重要性，推動了軟組織再生手術的需求。此外，人口老化和人工植牙治療的興起也進一步促進了該成長，因為健康、再生的牙齦組織對於植入的成功和壽命非常重要。

儘管牙科軟組織再生市場成長，但仍存在一些挑戰。其中一個主要挑戰是手術和材料的高成本。牙齦移植、富血小板血漿（PRP）療法和先進生物材料等再生治療通常成本高。

這些費用對於許多患者來說可能難以負擔，尤其是那些保險有限或沒有保險的患者。此外，手術的複雜性、專業培訓的需求以及對高品質材料的需求也增加了整體費用，使得這些治療難以被更廣泛的患者群體所接受。這種經濟障礙是阻礙軟組織再生技術在牙科行業中應用和發展的主要障礙之一。

全球牙科軟組織再生市場競爭激烈，許多主要企業引領著產業的成長與創新。Dentsply Sirona、Geistlich Pharma AG、Institut Straumann AG、Tissue Regenix、Septodont Holding、Regedent AG、Advanced Medical Solutions Group PLC、Regenity、ZimVie Inc. 和Henry Schein, Inc.。

這些公司大力投資研發，擴大產品系列，並建立策略夥伴關係關係，以提升競爭地位。他們致力於改進生物材料、再生技術和微創手術，以滿足對有效軟組織再生日益成長的需求。

這些公司提供種類繁多的尖端產品，滿足牙科專業人士和患者的多樣化需求，為市場發展做出了重要貢獻。隨著個人化、高效的軟組織再生解決方案需求的不斷成長，這些行業領導者將在塑造牙科行業的未來方面發揮關鍵作用。

牙科軟組織再生市場細分

細分 1：依產品類型

  • 自體移植
  • 合成生物材料
  • 膠原膠原蛋白膜
  • 其他

細分2：依應用

  • 植入
  • 牙周病
  • 其他

細分 3：依最終用戶

  • 牙科醫院
  • DSO 和獨立診所
  • 學術和研究機構

細分4：依地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

全球牙科軟組織再生市場最重要的新興趨勢之一是微創技術的日益普及。患者和牙科專業人士越來越青睞切口更小、恢復時間更短、不適感更少的治療，這推動了對雷射治療、果凍技術和基於生物材料的治療的需求。

這些進步使得介入措施更加精準，減少了術後併發症，並提高了患者滿意度。此外，富血小板血漿（PRP）、富血小板纖維蛋白（PRF）和幹細胞療法等再生技術的應用也日益普及，因為它們具有加速癒合和組織再生的潛力。這種向微創再生治療的轉變顯著提高了軟組織再生在牙科領域，尤其是在牙周和植入治療中的有效性和吸引力。

目錄

執行摘要

第1章 全球牙科軟組織再生市場：產業展望

  • 介紹
  • 市場趨勢
  • 法律規範
  • 專利分析
  • 案例研究
  • 產品基準
  • 市場動態

第2章 全球牙科軟組織再生市場（依產品類型），2024-2035

  • 自體移植
  • 合成生醫材料
  • 膠原膠原蛋白膜
  • 其他

第3章 全球牙科軟組織再生市場（依應用），2024-2035

  • 植入
  • 牙周病
  • 其他

第4章 2024-2035年全球牙科軟組織再生市場（依最終使用者）

  • 牙醫診所
  • DSO 和獨立診所
  • 學術研究機構

第5章 2024-2035年全球牙科軟組織再生市場（依地區）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 全球牙科軟組織再生市場：競爭格局與公司簡介

  • 關鍵策略和發展
  • 公司簡介
    • Dentsply Sirona
    • Geistlich Pharma AG
    • Institut Straumann AG
    • Tissue Regenix
    • Septodont Holding
    • Regedent AG
    • Advanced Medical Solutions Group PLC
    • Regenity
    • ZimVie Inc.
    • Henry Schein, Inc.

第7章 調查方法

Product Code: BHM3261SA

Global Dental Soft-tissue Regeneration Market, Analysis and Forecast: 2025-2035

Dental soft-tissue regeneration is a medical process aimed at restoring or regenerating the soft tissues in the oral cavity, such as the gums, periodontal ligaments, and mucous membranes.

This regenerative treatment focuses on promoting the natural healing and regeneration of tissues that have been damaged or lost due to conditions like gum disease (periodontitis), trauma, or following dental procedures such as tooth extractions or implants. The process is essential for maintaining the functional health and aesthetic appearance of the oral cavity. Soft-tissue regeneration plays a crucial role in preventing gum recession, supporting dental implant placement, and restoring the appearance of the gums, especially when there has been significant tissue loss.

Techniques used in dental soft-tissue regeneration include gum grafting, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, biomaterials, laser therapy, and ongoing research into stem cell therapies. This area of regenerative dentistry is increasingly important in periodontal disease management and implantology, where healthy, robust soft tissue is crucial for the long-term success of dental treatments.

One of the primary drivers of the Dental Soft-Tissue Regeneration market is the rising prevalence of periodontal diseases, such as gum recession and periodontitis. As these conditions become more widespread globally, there is an increasing demand for effective treatments to regenerate lost gum tissue, restore oral health, and improve aesthetics. Periodontal disease, which affects a significant portion of the population, often leads to the deterioration of gum tissues and can result in tooth loss if left untreated.

The need to address these issues, coupled with the growing awareness of the importance of maintaining healthy gums for overall oral health, is fueling the demand for soft-tissue regeneration procedures. Additionally, the aging population and the rise in dental implant procedures further contribute to this growth, as healthy, regenerated gum tissue is essential for the success and longevity of implants.

Despite the growth of the Dental Soft-Tissue Regeneration market, several challenges persist. One of the primary challenges is the high cost of procedures and materials. Regenerative treatments, including gum grafting, platelet-rich plasma (PRP) therapies, and advanced biomaterials, often involve significant costs.

These costs can be prohibitive for many patients, especially when insurance coverage is limited or unavailable. Additionally, the complexity of the procedures, the need for specialized training, and the requirement for high-quality materials add to the overall expense, making these treatments less accessible to a broader patient base. This financial barrier remains one of the key obstacles to the widespread adoption and growth of soft-tissue regeneration techniques in the dental industry.

The global Dental Soft-Tissue Regeneration market is indeed highly competitive, with numerous prominent players shaping the industry's growth and innovation. Companies like Dentsply Sirona, Geistlich Pharma AG, Institut Straumann AG, Tissue Regenix, Septodont Holding, Regedent AG, Advanced Medical Solutions Group PLC, Regenity, ZimVie Inc., and Henry Schein, Inc. are driving the development of advanced solutions in soft-tissue regeneration.

These companies are investing heavily in research and development, expanding their product portfolios, and forming strategic partnerships to enhance their competitive edge. Their efforts are focused on improving biomaterials, regenerative technologies, and minimally invasive procedures to meet the growing demand for effective soft-tissue restoration.

By offering a wide range of cutting-edge products and addressing the diverse needs of dental professionals and patients, these companies are contributing significantly to the market's evolution. As the demand for personalized and effective soft-tissue regeneration solutions increases, these industry leaders are poised to play a critical role in shaping the future of dental care.

Dental Soft-tissue Regeneration Market Segmentation:

Segmentation 1: by Product Type

  • Autografts
  • Synthetic Biomaterials
  • Collagen-Based Membranes
  • Others

Segmentation 2: by Application

  • Implantology
  • Periodontology
  • Others

Segmentation 3: by End User

  • Dental Hospitals
  • DSO's & Independent Clinics
  • Academic & Research Institutions

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

One of the most significant emerging trends in the global Dental Soft-Tissue Regeneration market is the increasing adoption of minimally invasive techniques. Patients and dental professionals are increasingly favoring treatments that involve smaller incisions, shorter recovery times, and less discomfort, which is driving the demand for laser therapy, microsurgical techniques, and biomaterial-based treatments.

These advancements allow for more precise interventions, reduce post-operative complications, and improve patient satisfaction. Moreover, the use of regenerative technologies such as Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), and stem cell therapies is gaining traction, as they offer potential for accelerated healing and tissue regeneration. This shift towards minimally invasive and regenerative treatments is significantly enhancing the effectiveness and appeal of soft-tissue regeneration in dentistry, especially in periodontal care and implantology.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Dental Soft-tissue Regeneration Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Dental Soft-tissue Regeneration Market (by Product Type), ($Billion), 2024-2035

  • 2.1 Autografts
  • 2.2 Synthetic Biomaterials
  • 2.3 Collagen-Based Membranes
  • 2.4 Others

3. Global Dental Soft-tissue Regeneration Market (by Application), ($Billion), 2024-2035

  • 3.1 Implantology
  • 3.2 Periodontology
  • 3.3 Others

4. Global Dental Soft-tissue Regeneration Market (by End User), ($Billion), 2024-2035

  • 4.1 Dental Hospitals
  • 4.2 DSO's & Independent Clinics
  • 4.3 Academic & Research Institutions

5. Global Dental Soft-tissue Regeneration Market (by Region), ($Billion), 2024-2035

  • 5.1 North America
    • 5.1.1 Key Findings
    • 5.1.2 Market Dynamics
    • 5.1.3 Market Sizing and Forecast
      • 5.1.3.1 North America Dental Soft-tissue Regeneration Market, by Country
        • 5.1.3.1.1 U.S.
        • 5.1.3.1.2 Canada
  • 5.2 Europe
    • 5.2.1 Key Findings
    • 5.2.2 Market Dynamics
    • 5.2.3 Market Sizing and Forecast
      • 5.2.3.1 Europe Dental Soft-tissue Regeneration Market, by Country
        • 5.2.3.1.1 Germany
        • 5.2.3.1.2 U.K.
        • 5.2.3.1.3 France
        • 5.2.3.1.4 Italy
        • 5.2.3.1.5 Spain
        • 5.2.3.1.6 Rest of the Europe
  • 5.3 Asia Pacific
    • 5.3.1 Key Findings
    • 5.3.2 Market Dynamics
    • 5.3.3 Market Sizing and Forecast
      • 5.3.3.1 Asia Pacific Dental Soft-tissue Regeneration Market, by Country
        • 5.3.3.1.1 China
        • 5.3.3.1.2 Japan
        • 5.3.3.1.3 India
        • 5.3.3.1.4 Australia
        • 5.3.3.1.5 Rest of Asia Pacific
  • 5.4 Rest of the World
    • 5.4.1 Key Findings
    • 5.4.2 Market Dynamics
    • 5.4.3 Market Sizing and Forecast

6. Global Dental Soft-tissue Regeneration Market: Competitive Landscape and Company Profiles

  • 6.1 Key Strategies and Development
    • 6.1.1 Mergers and Acquisitions
    • 6.1.2 Synergistic Activities
    • 6.1.3 Business Expansions and Funding
    • 6.1.4 Product Launches and Approvals
    • 6.1.5 Other Activities
  • 6.2 Company Profiles
    • 6.2.1 Dentsply Sirona
      • 6.2.1.1 Overview
      • 6.2.1.2 Top Products / Product Portfolio
      • 6.2.1.3 Top Competitors
      • 6.2.1.4 Target Customers/End-Users
      • 6.2.1.5 Key Personnel
      • 6.2.1.6 Analyst View
    • 6.2.2 Geistlich Pharma AG
      • 6.2.2.1 Overview
      • 6.2.2.2 Top Products / Product Portfolio
      • 6.2.2.3 Top Competitors
      • 6.2.2.4 Target Customers/End-Users
      • 6.2.2.5 Key Personnel
      • 6.2.2.6 Analyst View
    • 6.2.3 Institut Straumann AG
      • 6.2.3.1 Overview
      • 6.2.3.2 Top Products / Product Portfolio
      • 6.2.3.3 Top Competitors
      • 6.2.3.4 Target Customers/End-Users
      • 6.2.3.5 Key Personnel
      • 6.2.3.6 Analyst View
    • 6.2.4 Tissue Regenix
      • 6.2.4.1 Overview
      • 6.2.4.2 Top Products / Product Portfolio
      • 6.2.4.3 Top Competitors
      • 6.2.4.4 Target Customers/End-Users
      • 6.2.4.5 Key Personnel
      • 6.2.4.6 Analyst View
    • 6.2.5 Septodont Holding
      • 6.2.5.1 Overview
      • 6.2.5.2 Top Products / Product Portfolio
      • 6.2.5.3 Top Competitors
      • 6.2.5.4 Target Customers/End-Users
      • 6.2.5.5 Key Personnel
      • 6.2.5.6 Analyst View
    • 6.2.6 Regedent AG
      • 6.2.6.1 Overview
      • 6.2.6.2 Top Products / Product Portfolio
      • 6.2.6.3 Top Competitors
      • 6.2.6.4 Target Customers/End-Users
      • 6.2.6.5 Key Personnel
      • 6.2.6.6 Analyst View
    • 6.2.7 Advanced Medical Solutions Group PLC
      • 6.2.7.1 Overview
      • 6.2.7.2 Top Products / Product Portfolio
      • 6.2.7.3 Top Competitors
      • 6.2.7.4 Target Customers/End-Users
      • 6.2.7.5 Key Personnel
      • 6.2.7.6 Analyst View
    • 6.2.8 Regenity
      • 6.2.8.1 Overview
      • 6.2.8.2 Top Products / Product Portfolio
      • 6.2.8.3 Top Competitors
      • 6.2.8.4 Target Customers/End-Users
      • 6.2.8.5 Key Personnel
      • 6.2.8.6 Analyst View
    • 6.2.9 ZimVie Inc.
      • 6.2.9.1 Overview
      • 6.2.9.2 Top Products / Product Portfolio
      • 6.2.9.3 Top Competitors
      • 6.2.9.4 Target Customers/End-Users
      • 6.2.9.5 Key Personnel
      • 6.2.9.6 Analyst View
    • 6.2.10 Henry Schein, Inc.
      • 6.2.10.1 Overview
      • 6.2.10.2 Top Products / Product Portfolio
      • 6.2.10.3 Top Competitors
      • 6.2.10.4 Target Customers/End-Users
      • 6.2.10.5 Key Personnel
      • 6.2.10.6 Analyst View

7. Research Methodology

List of Figures

  • Figure: Global Dental Soft-tissue Regeneration Market (by Product Type), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market (by Application), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market Key Trends, Analysis

List of Tables

  • Table: Global Dental Soft-tissue Regeneration Market Dynamics, Impact Analysis
  • Table: Global Dental Soft-tissue Regeneration Market (by Region), $Billion, 2024-2035